Postmenopausal Vulvar and Vaginal Atrophy

• CLINICAL_TRIALS trial_result · 2022-05-09
  Clinical Trial Update: Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women [Phase 3]

  Phase 3 trial evaluating safety and efficacy of WC3011 (Estradiol Vaginal Cream) for postmenopausal vulvovaginal atrophy; trial completed wi…

• FDA approval · 2018-05-29
  FDA Approved: IMVEXXY — Original Application (Mayne Pharma LLC)

  FDA approved IMVEXXY (estradiol vaginal insert) through an Original Application (NDA208564) by Mayne Pharma LLC.

• FDA approval · 2017-11-01
  FDA Approved: ESTRING — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  FDA approved a supplemental application for ESTRING (estradiol vaginal ring) by Pfizer Laboratories Div Pfizer Inc to modify/expand its labe…

• FDA label_change · 2015-01-12
  FDA Approved: VAGIFEM — Supplemental Application (Novo Nordisk)

  FDA approved a supplemental application for VAGIFEM (estradiol) from Novo Nordisk.